Transplant News and Research

RSS

Pre-clinical studies provide important first steps to prepare for first clinical bladder transplant

A series of pre-clinical studies provide important first steps in developing techniques of robotic bladder transplantation in humans, as reported in the October issue of The Journal of Urology®, an Official Journal of the American Urological Association (AUA).

8 Sep 2023

NYU Langone offers the highest-quality kidney and lung transplant programs in the nation, new U.S. data reveals

The NYU Langone Transplant Institute offers the highest-quality kidney and lung transplant programs in the nation, according to new federal quality data, while its heart and liver transplant programs hold the highest organ survival rates in New York.

8 Sep 2023

Researchers develop first electronic device for continuously monitoring health of transplanted organs

Northwestern University researchers have developed the first electronic device for continuously monitoring the health of transplanted organs in real time.

8 Sep 2023

Vitamin C and D supplementation may reduce AML treatment complications

Patients with acute myeloid leukemia (AML) who received vitamin C and D supplements while undergoing intensive chemotherapy had lower rates of complications, such as infections, bleeding, and inflammation, when compared with similar, previously treated patients who did not receive these supplements.

7 Sep 2023

New gene therapy offers hope for beta thalassemia patients

UCSF Benioff Children's Hospital Oakland provides new therapy to first patient since FDA approval.

31 Aug 2023

Socioeconomic distress linked to worse outcomes after heart transplantation

People from socioeconomically distressed communities who underwent heart transplantation between 2004 and 2018 faced a 10% greater relative risk of experiencing graft failure and dying within five years compared to people from non-distressed communities.

31 Aug 2023

Universal approach could potentially expand CAR T cell therapy to all blood cancers

A broad new strategy could hold hope for treating virtually all blood cancers with CAR T cell therapy, which is currently approved for five subtypes of blood cancer.

31 Aug 2023

UQ-led clinical trial to test the effectiveness of diabetes drug for polycystic kidney disease

Patient recruitment is underway for a University of Queensland-led clinical trial to test the effectiveness of a diabetes drug to slow the progression of polycystic kidney disease (PKD).

30 Aug 2023

Man-made antibody successfully prevents organ rejection after transplantation

A man-made antibody successfully prevented organ rejection when tested in primates that had undergone a kidney transplant, Duke Health researchers report.

30 Aug 2023

New mechanism of action discovered for pulmonary distress in immunocompromised patients

When an immunocompromised person's system begins to recover and produce more white blood cells, it's usually a good thing – unless they develop a potentially deadly inflammatory condition.

30 Aug 2023

A move to cut drug prices has patients with rare diseases worried

For people with cystic fibrosis, like Sabrina Walker, Trikafta has been a life-changer.

30 Aug 2023

Unlocking tumor immune evasion: IL1RL1+ Treg cells and CAFs collaborate for immunotherapy resistance

Researchers demonstrated that the crosstalk between IL1RL1+ regulatory T-cells (Treg) and cancer-associated fibroblasts (CAFs) drives the tissue repairing.

30 Aug 2023

UC San Francisco scientists develop implantable bioreactor to treat kidney failure

Scientists at UC San Francisco are working on a new approach to treating kidney failure that could one day free people from needing dialysis or having to take harsh drugs to suppress their immune system after a transplant.

29 Aug 2023

Texas Heart Institute receives $2 million NIH grant to develop transplantable bioartificial hearts

The Texas Heart Institute recently received a five-year, $2 million grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health to advance the technology supporting development of transplantable bioartificial hearts.

25 Aug 2023

High cost of hepatic encephalopathy treatment may lead to medication non-adherence

Researchers from the University of Minnesota Medical School and College of Pharmacy have found that high costs for hepatic encephalopathy treatment in patients with end-stage liver disease were associated with decreased treatment retention for patients.

25 Aug 2023

Keck School of Medicine researchers receive $12 million grant to study early liver transplantation

Alcohol-associated liver disease accounts for 50% of liver-related deaths, and its rates are rising worldwide.

24 Aug 2023

Pioneering drug for rare kidney disease improves outcome for patients

A pioneering drug for a rare kidney disease prevents organ failure and significantly improves the outcome for patients, new research has confirmed.

24 Aug 2023

People with compromised immune systems less likely to have COVID-19 antibodies, study finds

New research has identified which people with compromised immune systems are less likely to have COVID-19 antibodies - making them more vulnerable to a severe infection.

23 Aug 2023

New matching system enables world's first four-way liver exchange

In a breakthrough in liver transplantation that may lead to the ability to connect more living donors and patients, a new matching system designed by a team led by Boston College economists enabled the world's first four-way liver exchange and a cascade of additional matches, researchers reported recently in the American Journal of Transplantation.

22 Aug 2023

Texas Heart Institute receives $1.14 million grant to develop first-in-class drug to treat cardiovascular disease

The National Heart, Lung, and Blood Institute (NHLBI) recently awarded The Texas Heart Institute (THI) a two-year, $1.14 million grant to develop a novel, first-in-class drug to treat cardiovascular disease (CVD) as a significant improvement to current treatment regimens -; specifically for adverse events arising from atherosclerosis.

22 Aug 2023

Transplant News and Research

Pre-clinical studies provide important first steps to prepare for first clinical bladder transplant

NYU Langone offers the highest-quality kidney and lung transplant programs in the nation, new U.S. data reveals

Researchers develop first electronic device for continuously monitoring health of transplanted organs

Vitamin C and D supplementation may reduce AML treatment complications

New gene therapy offers hope for beta thalassemia patients

Socioeconomic distress linked to worse outcomes after heart transplantation

Universal approach could potentially expand CAR T cell therapy to all blood cancers

UQ-led clinical trial to test the effectiveness of diabetes drug for polycystic kidney disease

Man-made antibody successfully prevents organ rejection after transplantation

New mechanism of action discovered for pulmonary distress in immunocompromised patients

A move to cut drug prices has patients with rare diseases worried

Unlocking tumor immune evasion: IL1RL1+ Treg cells and CAFs collaborate for immunotherapy resistance

UC San Francisco scientists develop implantable bioreactor to treat kidney failure

Texas Heart Institute receives $2 million NIH grant to develop transplantable bioartificial hearts

High cost of hepatic encephalopathy treatment may lead to medication non-adherence

Keck School of Medicine researchers receive $12 million grant to study early liver transplantation

Pioneering drug for rare kidney disease improves outcome for patients

People with compromised immune systems less likely to have COVID-19 antibodies, study finds

New matching system enables world's first four-way liver exchange

Texas Heart Institute receives $1.14 million grant to develop first-in-class drug to treat cardiovascular disease

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News